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Abstract
In mammals, the follicular development and following ovulation are regulated 
by reproductive hormones, while polycystic ovary syndrome (PCOS) is an endo-
crine disorder syndrome with reproductive dysfunction and abnormal glucose 
metabolism in most PCOS women. Its characteristics are hyperandrogenism, 
ovarian dysfunction, and the exclusion of other androgen excess or related dis-
eases. Its clinical characteristics are large antral follicle pool from which to recruit 
and persistent anovulation. The incidence of PCOS in women of childbearing age 
ranged from 4 to 12%. About one-third of infertility cases had no ovulation, and 
90% of them had PCOS. Therefore, further studying the regulatory mechanism 
of follicular hyperrecruitment and anovulation can provide theoretical basis for 
exploring the pathogenesis of PCOS and guiding clinical treatment, especially for 
protecting female fertility and preventing the occurrence of metabolic disorder 
syndrome. The present article will review the progress in endocrine characteristics 
and regulatory mechanism of follicular development and ovulation failure in the 
mammalian ovary.
Keywords: follicle-stimulating hormone, follicular development,  
luteinizing hormone, ovulation failure, polycystic ovary syndrome
1. Introduction
In mammals, the follicular development mainly includes several periods of 
primordial follicles, primary follicles, secondary follicles, tertiary follicles, and 
matured follicles. With the initiation of primordial follicle, primary follicles are 
gradually formed, then continue to develop to the secondary and tertiary follicles, 
and finally to matured follicles, which were divided into two stages: the selective 
follicle stage and the matured follicle stage. The development of follicles undergoes 
the development of early stage, the growth of antral follicles, the selection of domi-
nant follicles, the maturation, and ovulation of follicles. During an estrous cycle, 
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when thousands of primordial follicles develop to the ovulation stage, the number 
of ovulation accounts for only 0.1–0.2% of the total number of primordial follicles. 
Most of these follicles are atresia during the development, while the hormone 
regulation is accompanied by the follicular development all the time. Pituitary 
gonadotropin and steroid hormones promote the growth of oocytes, the prolifera-
tion of the follicular cells, and the formation of the follicular cavity, which plays an 
important role in the follicular development. Polycystic ovary syndrome (PCOS) 
is an endocrine disorder syndrome with reproductive dysfunction and abnormal 
glucose metabolism in most PCOS women [1], and its clinical characteristics are 
large antral follicle pool from which to recruit and persistent anovulation. Further 
understanding the regulatory mechanism of the follicular development and ovula-
tion in the ovaries will provide theoretical basis for the treatment of PCOS.
2. Hormonal regulation of the normal follicular development
Under physiological conditions, the growth and development of follicles are 
regulated by a variety of hormones, including pituitary gonadotropins (follicle-
stimulating hormone, FSH and luteinizing hormone, LH) and gonadal hormones 
(estrogen and androgen). Androgen promotes the growth and development of early 
follicles [2] and plays an important role in the follicular recruitment [3]; FSH recruits 
the follicles [4] and LH binds to its receptors to promote the androgen synthesis in the 
follicular membrane cells; FSH binds to its receptors to activate the aromatase activity 
in the granulosa cells and then to promote the transformation of androgen to estra-
diol; estrogen promotes the growth and differentiation of follicular cells and cooper-
ates with FSH to promote the development of the follicles; LH is secreted in a peak 
manner during the late follicular development for the ovulation of matured follicles.
2.1 Hormonal regulation of the early follicular development
It is generally believed that preantral follicles do not need the action of FSH, but 
studies have found that there are FSH receptors in the granulosa cells of preantral 
follicles, indicating that these follicles have the ability to respond to FSH very 
early. The threshold theory proposed by Brown in 1978 shows that the concentra-
tion of FSH is very important in the early follicle stage [5]. Once the FSH reaches 
the threshold, the follicle will enter the growth stage rapidly. The duration of 
FSH reaching the threshold and the extent of FSH exceeding the threshold will 
ultimately determine the number of matured follicles [5]. During the pre-antral fol-
licular phase, inhibin-containing follicular fluid was injected into mice and cattle, 
which reduced the concentration of FSH, caused follicular growth to stop, and 
delayed the appearance of new follicular waves; and artificial increase of FSH con-
centration would lead to larger follicular volume and more follicles [6]. Therefore, 
FSH plays an important role in the initiation and development of primordial 
follicles during the follicular development [7].
LH receptor (LHR) is widely distributed in nongonadal tissues besides follicular 
endometrial cells and Leydig cells. The expression of LHR was later than that of 
FSH receptor (FSHR) [6, 8]. The expression of LHR mRNA could only be detected 
5 days after the birth of the mouse offspring and 7 days after the birth of the rabbits 
when secondary follicles appeared in the ovaries [8]. In the estrous bovine and 
rabbit ovaries, LHR began to transcript in the follicular endometrial cells only after 
the follicles developed into antral follicles and follicular endometrium formed, and 
later in granulosa cells, indicating that LH had no direct effect on the development 
of preantral follicles.
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2.2 Hormonal regulation of the antral follicles
After FSH initiates the development of primordial follicles, it further promotes 
the formation of some follicles into the cavity and enters the growth of antral 
follicles. The continuous growth of antral follicles depends on the support of FSH, 
while FSH stimulates the growth and development of antral follicles, and at the 
same time stimulates granulosa cells to produce FSHR. With the increase of the 
number of FSHR, the response of follicular granulosa cells to FSHR increases, 
which promotes the continuous development of granulosa cells [9].
Follicular intima began to synthesize LHR, cholesterol side chain cleavage enzyme 
(P450scc), P450 17alpha hydroxylase (P450 17alpha), and 3beta hydroxysteroid 
dehydrogenase (3beta-HSD) after the formation of antral follicles. The develop-
ment of antral follicles is related to the synthesis of P450scc and P450arom enzymes 
by granulosa cells. LH acts on follicular endometrial cells, P450scc and 3beta-HSD 
catalyze the conversion of cholesterol to progesterone, and progesterone to androgen 
under the action of P450 17alpha and P450 C17,20 carbon chain lyase [10].
2.3 Hormonal regulation of the dominant follicles
Some of the first growing follicles were selected to continue to develop into 
dominant follicles. The remaining follicles in the same group were transformed into 
secondary follicles and gradually degenerated into atresia [11]. With the advent of 
dominant follicles, the concentration of FSH gradually decreased to the basic con-
centration and is maintained until the next peak. During the later selection period, 
the response ability of dominant follicles to FSH decreased, and the decrease of the 
peak value of FSH was obviously a necessary factor for the selection of dominant 
follicles, but not the only factor. LH also played an important role in this process.
During the selection process of dominant follicles, the number of FSH recep-
tors in granulosa cells remained unchanged, while the expression of LHR mRNA 
was initial, and the number of LHR increased gradually [12]. At the same time, 
the number of LH binding sites in endometrial cells increased when the dominant 
follicle was established, so the selection of dominant follicles began to change 
from FSH-dependent to LH-dependent one, and the number of LH receptors 
increased rapidly.
Androgen enters granulosa cells, FSH acts on granulosa cells, induces the 
proliferation and differentiation of granulosa cells, and increases the activity of 
P450arom, which converts androgen into estrogen [11]. With the increase of estra-
diol produced by follicles, estradiol has a feedback effect on pituitary gonadotropin, 
which makes the concentration of gonadotropin decrease slightly, inhibits the 
development of other follicles, and promotes atresia of other follicles. In addition, 
FSH has long sensitization to aromatase [13].
Inhibin (INH) is a glycoprotein hormone produced mainly by ovarian granu-
losa cells. It is a heterodimer composed of two subunits, alpha and beta [14]. INH 
stimulates androstenedione synthesis in the follicular membrane mediated by LH 
and enhances aromatase activity, thus increasing estradiol synthesis in granulosa 
cells. It is of great significance for follicular recruitment and selection of superior 
follicles. After the formation of dominant follicles, INH and 17beta-estradiol 
synthesized by granulosa cells increased, and inhibited FSH synthesis and release 
by blood circulation. On the one hand, the decrease of FSH synthesis restricts the 
further development of non-dominant follicles and makes them become atresia 
follicles; on the other hand, INH enhances the sensitivity of dominant follicles to 




2.4 Hormonal regulation of ovulation
Ovulation in animals is a complex process, involving a series of changes such as 
the rupture of matured follicles and excretion of matured oocyte. The hormone that 
fundamentally affects ovulation is LH. After selecting the dominant follicles, the 
gonadotropin-dependent transformation was completed, and the estrogen in the 
follicles increased rapidly, with the peak value of estradiol [16]. With the emer-
gence of estradiol peak, the pituitary response to gonadotropin-releasing hormone 
(GnRH) gradually increased, and the LH stored in pituitary increased in order to 
further provide hormones to the LH release pool, which reached the peak before 
ovulation. LH peak causes follicular wall ischemia to form a necrosis state of “physi-
ological atrophy,” leading to ovulation [9].
As in the case of LH, the concentration of FSH in blood increased briefly before 
ovulation and reached a peak again before ovulation. It is worth noting that LH 
must cooperate with a certain proportion of FSH in order to promote normal ovula-
tion. LH ruptures all the follicles on the ovary, but when they are used together, only 
matured follicles are discharged, indicating that FSH has a mechanism to inhibit the 
rupture of immatured follicles.
The appearance of LH peak activates adenylate cyclase in the follicular mem-
brane, increases cAMP, causes the luteinization of granulosa cells, increases pro-
gesterone content in the follicles, thus inhibits the positive feedback of estrogen to 
promote LH secretion [9], reduces the frequency of LH pulse [9], prolongs the dura-
tion of LH rise before ovulation, and ensures the sufficient time for LH and other 
gonadotropins to initiate follicular maturation and ovulation. At the same time, 
progesterone activates proteolytic enzymes, amylase, collagenase, and hyaluroni-
dase in the follicles. These enzymes act on the collagen structure of the follicular wall 
to decrease the tension, increase the expansibility, and finally cause the ovulation.
INH acts as a chemical signal of the pituitary gland to induce the number of 
developing follicles in the ovary and reduce the release of FSH to maintain the 
level of species-specific ovulation [17]. Estradiol transmits chemical signals to the 
hypothalamus during the follicular maturation, so INH is an important inducer of 
the follicular development, which controls the number of follicles by inhibiting the 
release of FSH [18].
3. Endocrine regulation of the follicular development in PCOS
PCOS patients are predominantly androgens and the excessive androgens are 
mainly androstenedione and testosterone [19]. Recent studies have found that 
other endocrine factors are also involved in the occurrence of PCOS, such as leptin, 
growth hormone, and so on.
3.1 Androgen
The increase of androgen level in follicular fluid blocks the development of 
dominant follicles [20], while the main mechanism of androgen excess in PCOS is as 
following. LH directly acts on the follicular membrane cells, increases the activity of 
P450 C17 enzyme in the cells, and causes the excessive androgen production in the 
follicular membrane cells; high level of INS increases the level of LH in PCOS patients, 
thus promoting the secretion of androgen by ovaries and adrenal glands; insulin-like 
growth factor (IGF)-I promote androgen production in the follicular membrane cells 
and adrenal cortical cells; and adrenal hyperfunction also produces a large amount of 
dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) [21].
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3.2 Gonadotropin
The serum FSH level of PCOS patients was lower than that of normal people, 
but low FSH level resulted in a large number of follicles accumulated and could 
not develop into dominant follicles, resulting in anovulation and the changes of 
polycystic ovarian [22, 23]. Although the persistent high androgen level in the 
ovary of PCOS patients cannot form dominant follicles, the small follicles in the 
ovary can still secrete estradiol. At the same time, the increase of estrone converted 
from androstenedione in the peripheral blood makes the persistent secretion of 
large amounts of estrogen and a certain level of estradiol act on the hypothalamus 
and pituitary gland, which has a positive feedback effect on LH, and increases its 
secretion amplitude and frequency. The level of LH is continuously high, and then 
stimulates the hyperplasia of follicular membrane, produces excessive androgens, 
significantly inhibits the role of LH in promoting estradiol secretion, which may be 
the cause of oocyte maturation disorder in PCOS patients [24].
3.3 Insulin
Insulin (INS) receptors are expressed in ovarian stromal cells, granulosa cells, 
and follicular membrane cells. INS promotes the follicular recruitment and stimu-
lates the synthesis of steroid hormones by follicular membrane cells and granulosa 
cells [25]. INS promotes androgen production by follicular membrane cells through 
the following pathways [26] and plays an important role in the production of 
hyperandrogenism [27]. INS increases androgen production by enhancing the 
activity of 17alpha-hydroxylase, increases androgen production by increasing the 
number of LH receptors or the affinity of LH to receptors, increases free androgen 
level by reducing the secretion of gonadal hormone binding globulin in the liver, 
and increases androgen level by inhibiting the secretion of IGF binding protein 
and enhancing the activity of serum IGF-I. INS resistance exists in PCOS patients, 
which leads to the hyperinsulinemia and increases androgen production and 
premature luteinization of granulosa cells, thus causing granulosa cell proliferation 
and follicular development to stagnate [26, 27].
3.4 Leptin
Leptin is a polypeptide hormone secreted by adipose tissue [28], which plays 
an important role in controlling reproductive capacity [29]. The disorder of leptin 
system is related to the pathogenesis of polycystic ovary [29–32]. Relatively high 
concentrations of leptin in serum and follicular fluid of PCOS patients resulted 
in lower fertilization, transfer, and pregnancy rates in vitro fertilization-embryo 
transfer (IVF-ET) [33]. The high concentration of leptin in PCOS patients inhibits 
the aromatase activity of granulosa cells, prevents the transformation of androgen 
to estrogen, induces hyperandrogenism, and inhibits follicular development [34]. 
In addition, leptin may block the selection and development of dominant follicles, 
leading to anovulation [35].
3.5 Growth hormone
Growth hormone (GH) is a hormone secreted by pituitary gland, which has 
physiological effects on the growth, development, and metabolism, which stimulates 
the follicular development, inhibits follicular atresia, and increases ovulation num-
ber [36]. GH directly regulates the gene expression of IGF-I or IGF-II and affects the 
synthesis of ovarian hormones. The impairment of GH secretion and the decrease 
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of GH level lead to anovulation in PCOS. In addition, INS inhibits the secretion of 
pituitary GH stimulated by basal and gonadotropin-releasing hormone and also 
stimulates the production of IGF-II, thus feedback inhibits GH secretion [36].
4. Molecular mechanism regulating the follicular development
Follicular development is regulated by many molecules and related signaling 
pathways in mammals. For example, prematured luteinization of granulosa cells in 
mouse follicles is associated with higher LH levels in the follicles, which results in 
the early meiosis of oocyte and changes in signal transduction, leading to follicular 
atresia [37]. In addition, activin/inhibin, BMP/Smad, and NPPC/NPR2 signaling 
pathways also play an active role in the development of ovarian follicles, which will 
be discussed in the present section.
4.1 Activin/inhibin signaling pathway
Activin is an intercellular signaling molecule secreted mainly by granulosa cells, 
and also an agonist-stimulating pituitary gland secreting FSH. Activin is involved 
in many biological functions of mammalian ovaries, including the survival of germ 
cells and the recruitment of primordial follicles, promotes the proliferation of 
granulosa cells and the expression of FSHR, delays the luteinization and atresia of 
follicles, and participates in the luteolysis [38–40]. Activin binds to type II receptor, 
starts the phosphorylation process, then activates type I receptor, phosphorylates 
the downstream signal molecule R-Smads, receptor Smad binding to phosphory-
lated R-Smads occurs the location transfer, and enters into the nucleus to bind with 
specific receptors, playing a regulatory role. Activin also promotes the proliferation 
and activity of granulosa cells through smad2/ERK5 signaling pathway, increases 
the secretion of stem cell factor (SCF, also known as Kit ligand, KL), and then 
specifically binds to the surface receptor c-Kit of oocytes. The expression level of 
SCF/c-Kit in rat ovary after binding is increased, thus promoting the development 
of oocytes [38].
Inhibin is a kind of macromolecule glycoprotein hormone secreted by the gonad, 
and its structure is similar to activin. Inhibin regulates the synthesis and secretion 
of pituitary FSH together with activin [41, 42]. During the development stage of 
dominant follicles, the concentration of inhibin A increased, which increased the 
sensitivity of dominant follicles to FSH and prevented dominant follicles from 
atresia. During the luteal formation stage, inhibin A mainly promotes the luteiniza-
tion of follicles, inhibin B mainly expresses in the small and medium follicles, and 
enhances FSH to prevent nondominant follicles from entering the preovulation 
stage, which was conducive to the screening of dominant follicles [43]. It was found 
that the level of inhibin B in the follicular fluid of PCOS patients decreased signifi-
cantly [44].
4.2 BMP/Smad signaling pathway
The signal transduction of bone morphogenetic proteins (Bmps) family can 
be divided into two main pathways: Smads-dependent pathway and non-Smads-
dependent pathway such as phosphatidylinositol 3 kinase (PI3K). Each member of 
the Smads family performs different functions in signal transduction pathways, 
which can be divided into three types: receptor-regulated Smads, CO-mediated 
Smads, and inhibitory Smads [45]. Bmps/Smads signaling pathway plays an impor-
tant role in regulating follicular growth, granulosa cell growth and differentiation, 
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oocyte maturation, and ovulation in mammals. Bmps bind to BMPR-II receptor 
on cell membrane and then make it phosphorylated. Phosphorylated BMPR-II 
receptor binds to BMP-I receptor to form a complex. BMP-I receptor is activated 
by corresponding protein kinase and phosphorylated. Then Smads signal molecule 
is activated. Activated R-Smads binding common CoSmad 4 forms Smad protein 
complex and enters the nucleus and specificity. DNA sequence binding start the 
promoter of downstream target gene, make downstream gene begin to transcribe 
[46–48], downstream signal molecule R-Smads also plays an important role in 
BMP/Smad signaling pathway. After Smad4 knockout, steroid hormone regulation 
was blocked, plasma progesterone level increased, and granulosa cells developed 
premature luteinization, which eventually led to premature ovarian failure [49].
4.3 NPPC/NPR2 signaling pathway
Natriuretic peptide family widely exists in animal brain, heart, and other 
tissues and organs, which has the functions of maintaining blood pressure and 
blood volume stability, promoting fat metabolism and cartilage growth. The family 
consists of three ligands and three specific receptors in mammals. Ligands exist 
in the form of precursor peptides, namely atrial natriuretic peptide (ANP, also 
known as NPPA), brain natriuretic peptide (BNP, also known as NPPB), C-type 
natriuretic peptide (CNP, also known as NPPC), and specific receptors exist in 
the form of dimers, namely natriuretic peptide receptor A (NPRA, also known as 
NPR1), natriuretic peptide receptor B (NPRB, also known as NPR2), and natri-
uretic peptide receptor C (NPRC, also known as NPR3) [50]. NPPC/NPR signaling 
pathway plays an important role in inhibiting premature maturation of mammalian 
oocytes. The combination of NPPC and NPR2 produced by granulosa cells of the 
follicular parietal layer stimulates the production of cGMP, which enters into the 
oocyte through interstitial links between oocyte and granulosa cells [51], inhibits 
the activity of phosphodiesterase (PDE3A), and decreases the degree of hydrolysis 
of cAMP, thus stabilizing at a higher level. The protein kinase PKA dependent 
on cAMP regulates the activity of maturation-promoting factor (MPF) through 
phosphatase cell division cycle 25 (CDC25), Wee1 kinase, and myelin transcription 
factor Myt1. CDC25 dephosphorylated cyclin-dependent kinase 1 (CDK1), Wee1 
and Myt1 phosphorylated CDK1, phosphorylated CDK1 and related complexes 
inactivated, and ultimately inhibited the maturation of oocytes.
5. Conclusion
Nowadays, great achievements have been made in the molecular mechanism of 
follicular development in mammals. At present, many signaling pathways have been 
proved to play a very important role during the follicular growth and development, 
and some of them have been thoroughly studied. However, there are still some 
problems related to signaling pathways, such as how mammals initiate primordial 
follicular development and which downstream target genes are involved in signal-
ing pathways. Follicular dysplasia in PCOS patients is closely related to apoptosis of 
granulosa cells, follicular atresia, and oocyte degeneration. Its mechanism is related 
to endocrine dysfunction, as well as regulation factors and their receptors in the 
ovary. Although PCOS patients can obtain a large number of oocytes, the low rate 
of matured oocytes, the low rate of high-quality embryos, the low pregnancy rate, 
and the high abortion rate make clear the related factors of oocyte degeneration 
and atresia regulation, which is of great significance to the application of assisted 
reproductive technology in PCOS patients. Therefore, further understanding the 
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molecular mechanism regulating the follicular development in mammals still 
requires further study on the biology and gene expressions related to the follicular 
development, which is of great significance for the treatment of mammalian repro-
ductive infertility and other diseases.
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